Stamford, CT -- (SBWIRE) -- 01/11/2014 -- High Rising Stocks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: North American Palladium Ltd (USA)(NYSEMKT:PAL), Neuralstem, Inc.(NYSEMKT:CUR), Mast Therapeutics Inc(NYSEMKT:MSTX), ImmunoCellular Therapeutics Ltd(NYSEMKT:IMUC)
North American Palladium Ltd (USA)(NYSEMKT:PAL) opened the session at $0.66, remained amid the day range of $0.63 - $0.72, and closed the session at $0.670. The stock showed a positive performance of 7.56% in previous trading session. The stock gained a volume of 3.03 million shares and the average volume of the stock remained 3.78 million shares. North American Palladium Ltd. produces precious metals in Canada. It explores for palladium, platinum, nickel, gold, copper, and other metals. North American Palladium Ltd. was founded in 1968 and is headquartered in Toronto, Canada.
Why Should Investors Buy PAL After The Recent Gain? Just Go Here and Find Out
Neuralstem, Inc.(NYSEMKT:CUR) traded with volume of 2.73 million shares in the prior session and the average volume of the stock remained 886,802.00 shares. The stock showed a negative movement of -5.61% and closed its session at $3.53. The market capitalization of the stock remained 299.53 million. Neuralstem, Inc., a biopharmaceutical company, focuses on the development and commercialization of treatments for central nervous system disease based on human neural stem cells and the use of small molecule compounds.
Why Should Investors Buy CUR After the Recent Fall? Just Go Here and Find Out
Mast Therapeutics Inc(NYSEMKT:MSTX) exchanged 2.69 million shares and the average volume remained 1.94 million shares. The stock dropped -2.75% and closed the session at $0.530. The beta of the stock remained 1.06 and the EPS of the stock remained -0.35. The shares outstanding of the stock remained 102.71 million. Mast Therapeutics, Inc., a biopharmaceutical company, focuses on developing therapies for serious or life-threatening diseases. Its lead product candidate includes MST-188, a product candidate that has hemorheologic, cytoprotective, and anti-inflammatory properties, which is in phase 3 study for the treatment of sickle cell disease in patients.
Has MSTX Found The Bottom And Ready To Gain Momentum? Find Out Here
ImmunoCellular Therapeutics Ltd(NYSEMKT:IMUC) opened the session at $0.99, remained amid the day range of $0.94 - $1.00, and closed the session at $0.989. The stock showed a positive performance of 7.61% in previous trading session. The stock gained a volume of 2.69 million shares and the average volume of the stock remained 4.03 million shares. ImmunoCellular Therapeutics, Ltd., a clinical-stage biotechnology company, engages in developing and commercializing immune-based therapies for the treatment of brain, ovarian, and other solid tumors. The company is based in Woodland Hills, California.
For How Long IMUC’s Gloss will Attract Investors? Find out via this report
High Rising Stocks provides investors with the hottest penny stock alerts on a regular basis. It carries Hot Penny Stocks and Penny Stock Newsletter, we will send you alerts through our Free Penny Stock Newsletters with High Yielding alerts, market forecasting, stock tips and strategies, and offer you the tools to help you along the way with the goal of keeping you loyal to our service.
Carriage Consulting Group, High Rising Stocks, their Members, officers, directors, employees, affiliates, or any other related person(s) (collectively, “High Rising Stocks”) are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. High Rising Stocks as defined are neither licensed nor qualified to provide investment advice and you are specifically and adamantly advised not to rely upon anything said/posted/communicated/implied or expressed by High Rising Stocks as defined.
Read full Disclaimer at: http://highrisingstocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)